Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist.

Source:http://linkedlifedata.com/resource/pubmed/id/20124517

Download in:

View as

General Info

PMID
20124517